Rare diseases
Investigational molecules
Locations
ul. Barwicka 14 h/4, 60-192 Poznan, Poland
Praktyka Lekarska Małgorzata Wojtanowska-Bogacka in Poznan, Poland specialises in clinical trials of conditions such as Major depression, Anhedonia, Cognitive disorder, Schizophrenia, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in Major Depressive Disorder (MDD), focusing on innovative adjunctive therapies to enhance treatment outcomes. The center's work in this area aims to improve the efficacy of existing antidepressant treatments by integrating new therapeutic agents.
By exploring flexible dosing regimens and novel compounds, the center contributes significantly to the understanding and management of MDD, offering hope for patients with inadequate responses to standard treatments.
Specializing in the treatment of cognitive impairment associated with schizophrenia, the medical center is pioneering research into therapeutic interventions that target cognitive deficits. This research is crucial for enhancing the quality of life and functional outcomes for individuals with schizophrenia.
Through adaptive, randomized, and placebo-controlled studies, the center is advancing the field of cognitive disorder treatment, providing new insights into effective management strategies for schizophrenia.
Clinical trials currently enrolling participants at this site.
Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
PolandStudy on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms
PolandLong‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder
PolandA study of azetukalner compared to placebo for adults with moderate-to-severe major depressive disorder
PolandTesting Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment
PolandStudy on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia
PolandStudy on RL-007 for Improving Cognitive Impairment in Schizophrenia Patients
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
